by Vandana Singh | Feb 25, 2026 | General
Novo Nordisk A/S (NYSE:NVO) shares are down during Wednesday’s premarket session. The down move comes as the company announced plans to cut the list prices of its GLP-1 drugs by up to 50% in the U.S. starting in 2027, adding pressure as broader markets edged lower....
by Khyathi Dalal | Feb 25, 2026 | General
Bitcoin (CRYPTO: BTC) is back above $66,000 on renewed ETF inflows, with on-chain data suggesting the asset may have meaningful upside if correlations normalize. BTC Has Room To Grow Bitcoin has historically traded in close alignment with the S&P 500, typically...
by Surbhi Jain | Feb 25, 2026 | General
ImmunityBio Inc (NASDAQ:IBRX) has already delivered one of 2026’s most explosive stock moves. But the conditions behind its 471% year-to-date surge suggest the most volatile phase may still lie ahead. Source: Benzinga IBRX stock surged nearly 86% in the past...
by Vandana Singh | Feb 25, 2026 | General
Charles River Laboratories (NYSE:CRL) on Wednesday announced significant plans to divest parts of its business. Charles River agreed to divest its CDMO and Cell Solutions businesses, along with certain European Discovery Services assets. Planned Divestiture Of CDMO...
by Benzinga Insights | Feb 25, 2026 | General
Fortinet (NASDAQ:FTNT) has outperformed the market over the past 15 years by 9.62% on an annualized basis producing an average annual return of 21.17%. Currently, Fortinet has a market capitalization of $56.20 billion. Buying $100 In FTNT: If an investor had bought...
Recent Comments